Atlas Trials

Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities

Clinical trial NCT04525300 · UNKNOWN

Trial details

NCT number
NCT04525300
Sponsor
Xiangya Hospital of Central South University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Obesity
Start date
2020-05-24
Primary completion
2022-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.